December 25, 2024 07:43 pm (IST)
MSN Labs initiates Phase-III clinical trials for COVID-19 treatment drug
May 25, 2021, at 08:49 pm
Hyderabad/UNI: MSN Laboratories Private Limited, the front-runner in introducing various drugs in the treatment of COVID-19 and its complications, on Tuesday announced that it is initiating phase III clinical trials of ‘Molnupiravir’ capsules for the treatment of COVID-19 in India.
Latest Headlines